- Home
- ZEO vs AWH Comparison
ZEO vs AWH Comparison
Compare ZEO & AWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZEO
- AWH
- Stock Information
- Founded
- ZEO 2005
- AWH 1993
- Country
- ZEO United States
- AWH United States
- Employees
- ZEO N/A
- AWH N/A
- Industry
- ZEO
- AWH Medical/Dental Instruments
- Sector
- ZEO
- AWH Health Care
- Exchange
- ZEO NYSE
- AWH Nasdaq
- Market Cap
- ZEO 14.6M
- AWH 13.5M
- IPO Year
- ZEO N/A
- AWH N/A
- Fundamental
- Price
- ZEO $1.69
- AWH $0.80
- Analyst Decision
- ZEO
- AWH Buy
- Analyst Count
- ZEO 0
- AWH 2
- Target Price
- ZEO N/A
- AWH $4.40
- AVG Volume (30 Days)
- ZEO 3.1M
- AWH 58.9K
- Earning Date
- ZEO 11-20-2024
- AWH 11-11-2024
- Dividend Yield
- ZEO N/A
- AWH N/A
- EPS Growth
- ZEO N/A
- AWH N/A
- EPS
- ZEO 0.67
- AWH N/A
- Revenue
- ZEO $95,455,763.00
- AWH $8,923,000.00
- Revenue This Year
- ZEO N/A
- AWH $15.59
- Revenue Next Year
- ZEO N/A
- AWH $108.47
- P/E Ratio
- ZEO $2.58
- AWH N/A
- Revenue Growth
- ZEO N/A
- AWH N/A
- 52 Week Low
- ZEO $1.14
- AWH $0.74
- 52 Week High
- ZEO $12.34
- AWH $6.01
- Technical
- Relative Strength Index (RSI)
- ZEO 42.71
- AWH 38.68
- Support Level
- ZEO $1.55
- AWH $0.76
- Resistance Level
- ZEO $1.96
- AWH $0.89
- Average True Range (ATR)
- ZEO 0.37
- AWH 0.07
- MACD
- ZEO -0.01
- AWH 0.01
- Stochastic Oscillator
- ZEO 8.08
- AWH 40.00
About ZEO ZEO ENERGY CORP
Zeo Energy Corp is a vertically integrated provider of residential solar energy systems, other energy efficient equipment and related services currently serving customers in Florida, Texas, Arkansas, and Missouri. Its primary business activity is selling and installing residential solar energy systems that homeowners use to supplement the amount of usable electricity required to power their homes.
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.